Morningstar

Altria Lifts Earnings Outlook as 3Q Profit, Revenue Climb

Provided by Dow Jones

By Connor Hart 




  Altria Group raised its full-year earnings outlook after reporting higher profit and revenue in the latest quarter, as the company's cigarette brands scooped up market share and it invested in its smoke-free portfolio. 



  The tobacco company posted a third-quarter profit of $2.52 billion, or $1.51 a share, compared with $2.38 billion, or $1.41 a share, a year earlier. 



  Stripping out certain one-time items, earnings were $1.52 a share. Analysts polled by FactSet expected adjusted earnings of $1.51 a share. 



  Revenue ticked up 1% to $6.13 billion. 



  Within Altria's smokable-products division, which includes Marlboro and Virginia Slims cigarettes, revenue edged 0.8% higher to $5.43 billion. 



  Revenue from the company's oral-tobacco business, which includes on! nicotine pouches, came in roughly flat at $688 million. 



  Chief Executive Sal Mancuso said Altria Group's cigarette brands are gaining market share. The company continues to invest in its smoke-free brands, including by launching new variants and flavors of its products, he added. 



  Looking ahead, Altria now expects adjusted earnings of $5.66 to $5.74 a share, compared with a prior outlook for $5.56 to $5.72 a share. 



  "Our strong performance through the first nine months and confidence in our full-year plan allowed us to raise our earnings guidance for the year," Mancuso said. 



  Shares climbed 1.4%, to $74, in premarket trading Thursday. 





  Write to Connor Hart at connor.hart@wsj.com 





  (END) Dow Jones Newswires



  October 29, 2026 08:05 ET (12:05 GMT)


Copyright (c) 2026 Dow Jones & Company, Inc.
  

					The articles, information, and content displayed on this webpage may
					include materials prepared and provided by third parties. Such
					third-party content is offered for informational purposes only and
					is not endorsed, reviewed, or verified by Morningstar.
				
 

					Morningstar makes no representations or warranties regarding the
					accuracy, completeness, timeliness, or reliability of any third-party
					content displayed on this site. The views and opinions expressed in
					third-party content are those of the respective authors and do not
					necessarily reflect the views of Morningstar, its affiliates, or employees.
				
 

					Morningstar is not responsible for any errors, omissions, or delays
					in this content, nor for any actions taken in reliance thereon.
					Users are advised to exercise their own judgment and seek independent
					financial advice before making any decisions based on such content.
					The third-party providers of this content are not affiliated with
					Morningstar, and their inclusion on this site does not imply any
					form of partnership, agency, or endorsement.
				
 

				Popular
				
 
  
 
 
 
 
5 Stocks to Buy Trading at Big Discounts
 
Plus, what recent bond market volatility means for investors. 
 
 
David Sekera, CFA and Sarah Hansen 
 
 
 
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
 
Defense spending and booming data center demand could provide powerful tailwinds for these 4-star stocks. 
 
 
David Sekera, CFA, Sarah Hansen, and Jess Bebel 
 
 
 
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
 
Despite a looming patent cliff, a strong drug pipeline and 4.1% yield give investors reasons for optimism. 
 
 
Karen Andersen, CFA 
 
 
 
What 7 Key Market Indicators Are Telling Investors Right Now
 
US equity valuations have retreated from their recent highs, but all 7 major market indicators remain above their long-term averages. 
 
 
Amy C. Arnott, CFA 
 
 
 
There Are Three Paths Forward for the AI Boom. Two of Them Lead to Lower Interest Rates
 
Mass layoffs or a spending slowdown would likely require hefty Fed rate cuts. 
 
 
Preston Caldwell 
 
 
 
 

			Sponsor Center